• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】42525

【品名】methyl 5-methoxy-3,4-dihydro-1-naphthalenecarboxylate

【CA登记号】

【 分 子 式 】C13H14O3

【 分 子 量 】218.25236

【元素组成】C 71.54% H 6.47% O 21.99%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(II)

Treatment of carboxylic acid (I) with MeOH and H2SO4 yields methyl ester (II), which is then converted into cyano derivative (III) by reaction with LiCN in DMF and AcOH. Hydrolysis of (III) with aqueous KOH in EtOH provides dicarboxylic acid (IV), which is cyclized by means of Ac2O to give the dicarboxylic anhydride (V). Alternatively, (V) can be obtained by condensation of ester (VI) with diethyl oxalate (A) in Et2O in the presence of t-BuOK to afford (VII), which is cyclized with H2SO4 and submitted to catalytic hydrogenation over Pd/C. Condensation of anhydride (V) with (S)-alpha-methylbenzylamine yields a mixture of imides, from which (3aR,9bR)-(IX) is obtained by crystallization. Reduction of (3aR,9bR)-(IX) with BH3·THF followed by hydrogenation over Pd/C affords isoindole derivative (X), which is then alkylated with chloroacetonitrile (XI) in acetonitrile in the presence of DIEA and reduced with LiAlH4 to give the primary amine (XII). Treatment of (XIII) with POCl3 and Et3N yields 2-chloro-3-cyanopyrazine (XIV), which is oxidized to provide (XV) by means of K2S2O8 in H2SO4. Treatment of N-oxide (XV) with ethyl thioglycolate (XVI) and NaOEt in DMF affords pyrazinothiophene (XVII), which is then chlorinated with POCl3 to give (XVIII). Finally, reaction of amine (XII) with (XVIII) and triphosgene in toluene and Et3N affords the desired product.

1 Meyer, M.D.; Altenbach, R.J.; Basha, F.Z.; Carroll, W.A.; Drizin, I.; Kerwin, J.F. Jr.; Lebold, S.A.; Lee, E.L.; Elmore, S.W.; Sippy, K.B.; Tietje, K.R.; Wendt, M.D.; Yamamoto, D.M. (Abbott Laboratories Inc.); Tricyclic substd. hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists. EP 0808318; US 5597823; WO 9622992 .
2 Basha, F.Z.; Meyer, M.D.; Altenbach, R.J.; et al.; Structure-activity studies for a novel series of tricycic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of bening prostatic hyperplasia (BPH). J Med Chem 2000, 43, 8, 1586.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 17571 Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate 95-92-1 C6H10O4 详情 详情
(I) 42524 5-methoxy-3,4-dihydro-1-naphthalenecarboxylic acid C12H12O3 详情 详情
(II) 42525 methyl 5-methoxy-3,4-dihydro-1-naphthalenecarboxylate C13H14O3 详情 详情
(III) 42526 methyl 2-cyano-5-methoxy-1,2,3,4-tetrahydro-1-naphthalenecarboxylate C14H15NO3 详情 详情
(IV) 42527 5-methoxy-1,2,3,4-tetrahydro-1,2-naphthalenedicarboxylic acid C13H14O5 详情 详情
(V) 42528 (3aR,9bR)-6-methoxy-3a,4,5,9b-tetrahydronaphtho[1,2-c]furan-1,3-dione C13H12O4 详情 详情
(VI) 42529 ethyl 4-(2-methoxyphenyl)butanoate C13H18O3 详情 详情
(VII) 42530 diethyl 2-(2-methoxyphenethyl)-3-oxosuccinate C17H22O6 详情 详情
(VIII) 20042 (1S)-1-phenyl-1-ethanamine; (1S)-1-phenylethylamine C8H11N 详情 详情
(IX) 42531 (3aR,9bR)-6-methoxy-2-[(1S)-1-phenylethyl]-3a,4,5,9b-tetrahydro-1H-benzo[e]isoindole-1,3(2H)-dione C21H21NO3 详情 详情
(X) 42532 (3aR,9bR)-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]isoindol-6-yl methyl ether; (3aR,9bR)-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]isoindole C13H17NO 详情 详情
(XI) 14443 2-chloroacetonitrile; chloroacetonitrile 107-14-2 C2H2ClN 详情 详情
(XII) 42533 (3aR,9bR)-2-(2-aminoethyl)-6-methoxy-3a,4,5,9b-tetrahydro-1H-benzo[e]isoindole-1,3(2H)-dione C15H18N2O3 详情 详情
(XIII) 42534 3-hydroxy-2-pyrazinecarboxamide 55321-99-8 C5H5N3O2 详情 详情
(XIV) 42535 3-chloro-2-pyrazinecarbonitrile 55557-52-3 C5H2ClN3 详情 详情
(XV) 42536 3-chloro-2-cyanopyrazin-1-ium-1-olate C5H2ClN3O 详情 详情
(XVI) 23995 ethyl 2-sulfanylacetate 2713-34-0 C4H8O2S 详情 详情
(XVII) 42537 7-amino-6-(ethoxycarbonyl)thieno[2,3-b]pyrazin-1-ium-1-olate C9H9N3O3S 详情 详情
(XVIII) 42538 ethyl 7-amino-2-chlorothieno[2,3-b]pyrazine-6-carboxylate C9H8ClN3O2S 详情 详情
Extended Information